Bioventus Inc. (BVS) — Annual Report

Key Insights

• Bioventus Inc. (BVS) reported a decline in revenue and profitability in 2025 compared to previous years, which could raise concerns for investors.
• The company has significant exposure to supplier concentration risk, with four key suppliers accounting for a substantial portion of its revenue and accounts payable.
• Bioventus has made investments in property, plant, and equipment, as well as intangible assets like intellectual property and developed technology rights, which could impact its cash flow and financial position.